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Ciliary neurotrophic factor (CNTF) induces weight loss in obese rodents and humans
through activation of the hypothalamic Jak-STAT (Janus kinase-signal transducer and
activator of transcription) signaling pathway. Here, we tested the hypothesis that
CNTF also affects the brainstem centers involved in feeding and energy balance
regulation. To this end, wild-type and leptin-deficient (ob/ob and db/db) obese mice were
acutely treated with intraperitoneal recombinant CNTF. Coronal brainstem sections were
processed for immunohistochemical detection of STAT3, STAT1, STAT5 phosphorylation
and c-Fos. In wild-type mice, CNTF treatment for 45min induced STAT3, STAT1, and
STAT5 phosphorylation in neurons as well as glial cells of the area postrema; here, the
majority of CNTF-responsive cells activated multiple STAT isoforms, and a significant
proportion of CNTF-responsive glial cells bore the immaturity and plasticity markers
nestin and vimentin. After 120min CNTF treatment, c-Fos expression was intense in
glial cells and weak in neurons of the area postrema, it was intense in several neurons
of the rostral and caudal solitary tract nucleus (NTS), and weak in some cholinergic
neurons of the dorsal motor nucleus of the vagus. In the ob/ob and db/db mice,
Jak-STAT activation and c-Fos expression were similar to those induced in wild-type
mouse brainstem. Treatment with CNTF (120min, to induce c-Fos expression) and leptin
(25min, to induce STAT3 phosphorylation) demonstrated the co-localization of the two
transcription factors in a small neuron population in the caudal NTS portion. Finally, weak
immunohistochemical CNTF staining, detected in funiculus separans, and meningeal
glial cells, matched the modest amount of CNTF found by RT-qPCR in micropunched
area postrema tissue, which in contrast exhibited a very high amount of CNTF receptor.
Collectively, the present findings show that the area postrema and the NTS exhibit high,
distinctive responsiveness to circulating exogenous and, probably, endogenous CNTF.
Keywords: area postrema, solitary tract nucleus, dorsal motor nucleus of the vagus, brainstem, Stat signaling,
c-Fos, nestin, cholinergic
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INTRODUCTION
Ciliary neurotrophic factor (CNTF), originally isolated from
chick embryo ciliary ganglion, was first characterized for its
action on parasympathetic cholinergic neurons (Adler et al.,
1979; Skaper et al., 1984). It exerts important effects on neuronal
and glial precursors during the development of the central
(CNS) and peripheral nervous system, and on the postnatal
maintenance of sensory, sympathetic, and motor neurons
(Sendtner et al., 1994; Sleeman et al., 2000). Its distinctive
neuroprotective action on cortical, bulbar, and spinal motor
neurons has prompted administration of human recombinant
CNTF to patients with neurodegenerative conditions such as
Huntington’s disease and amyotrophic lateral sclerosis in a
number of clinical trials (ACTS, 1996; Miller et al., 1996). The
substantial weight loss seen in these patients after systemic CNTF
administration unveiled a role for it in human body metabolism
and energy balance regulation. Importantly, the weight-reducing
effect of exogenous CNTF has later been confirmed in leptin-
resistant obese patients treated subcutaneously with Axokine, a
form of human CNTF with enhanced specificity and potency
(Ettinger et al., 2003). The mechanisms by which exogenous
CNTF regulates the energy balance are thought to involve both
hypothalamic centers, where it promotes satiety, and peripheral
organs, including muscle, liver, and adipose tissue, where it
increases insulin sensitivity and energy expenditure (Matthews
and Febbraio, 2008; Pasquin et al., 2015).
Along with the other members of the interleukin-6 family,
CNTF interacts at the cellular level with a heterotrimeric receptor
composed of CNTF receptor α (CNTFRα), glycoprotein-130,
and leukemia inhibitor factor receptor (Panayotatos et al.,
1995). CNTF binding to its three-part receptor complex
activates the Janus family of tyrosine kinases (Jak1/Jak2),
leading to tyrosine phosphorylation, dimerization, and nuclear
translocation of signal transducers and activators of transcription
(STATs; Heinrich et al., 2003; Simi and Ibanez, 2010).
Activation of Jak-STAT3 signaling in neuropeptide Y (NPY)-
and pro-opiomelanocortin (POMC)-containing neurons in the
hypothalamic arcuate nucleus (Lambert et al., 2001; Anderson
et al., 2003; Janoschek et al., 2006) and generation of new leptin-
responsive neurons in the mediobasal hypothalamus (Kokoeva
et al., 2005) have been suggested to be the mechanisms by
which CNTF induces the anorectic response. However, in a
previous paper we showed that in the tuberal hypothalamus
CNTF, besides activating STAT3 in arcuate nucleus neurons, also
induced STAT3, STAT1, and STAT5 phosphorylation in median
eminence (ME) cells, and that a considerable proportion of
CNTF-responsive ME cells were glial cells displaying markers of
immaturity (Severi et al., 2015). These findings suggest that the
hypothalamic action of CNTF is more complex than previously
anticipated, and may also involve the ME, the circumventricular
organ of the tuberal hypothalamus, where circulating satiety
factors have been suggested to gain access to arcuate nucleus
neurons involved in energy balance regulation (Langlet, 2014).
In mammals, energy balance homeostasis is influenced
by a variety of circulating signaling molecules, secreted in
response to eating and fasting, which provide afferent metabolic
and nutritional information to the CNS. Many of these
factors are peptides that modulate food intake and energy
expenditure by acting on hypothalamic as well as brainstem
neuronal circuits (Morton et al., 2014; Schneeberger et al.,
2014). In the brainstem, three main structures are involved
in regulating energy homeostasis: (i) the area postrema, the
brainstem circumventricular organ lacking the blood-brain
barrier and sensing circulating factors, which is found in
the dorsal medulla; (ii) the nucleus of the solitary tract
(NTS), the main sensory relay for the viscera, including the
gastrointestinal tract; and (iii) the dorsal motor nucleus of the
vagus (DMX), which is the source of vagal efferents controlling
gut motility and secretion, among other visceral responses.
These structures are collectively referred to as the dorsal vagal
complex (DVC), because they are strongly anatomically and
functionally integrated to provide autonomic, behavioral and
endocrine responses to energy-related peripheral cues (Young,
2012).
Here we test the hypothesis that, similar to other, better
characterized satiety factors, circulating CNTF may act not
only at the hypothalamic level, but also on brainstem centers.
Notably, CNTF has been shown to activate immediate early
genes (SOCS-3, c-Fos, and tis-11) in several rodent brainstem
areas, including the area postrema and the NTS (Kelly et al.,
2004). To characterize the action(s) of circulating CNTF in
the DVC, the expression and distribution of (Tyr705)-phospho-
STAT3 (P-STAT3), (Tyr701)-P-STAT1, (Tyr694)-P-STAT5, and
c-Fos were evaluated by immunohistochemical techniques
in coronal brainstem sections from normal and genetically
obese (leptin-deficient) mice treated with an intraperitoneal
injection of rat recombinant CNTF and/or leptin for different
periods of time. Co-localization experiments with neuronal
and glial markers and confocal microscopy analyses were
performed to establish the phenotype of the CNTF-responsive
cells. Finally, CNTF and CNTFRα expression was quantified
by RT-qPCR in specimens micropunched from midsagittal
brain sections and containing the area postrema or the
mediobasal hypothalamus and the ME. Collectively, the results
suggest that the mouse area postrema and NTS are sites of
high responsiveness to circulating exogenous and, probably,
endogenous CNTF, which acts on the brainstem DVC in
a distinctively different manner compared with other satiety
factors.
MATERIAL AND METHODS
Animals
Adult Swiss CD-1 mice and adult ob/ob, db/db, and wild type
C57BL/6 mice were purchased from Charles River Laboratories
(Calco, Italy). CNTF-deficient mice, where the CNTF gene has
been eliminated by homologous recombination (Masu et al.,
1993), were kindly provided by Dr. M. Sendtner (Wuerzburg,
Germany). All animals were housed in plastic cages in constant
environmental conditions (12 h light/dark cycle at 22◦C) with ad
libitum access to food and water. Handling was limited to cage
cleaning. All efforts were made to minimize animal suffering and
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to reduce the number of animals used. Experiments were carried
out in accordance with EC Council Directive 86/609/EEC of 24
November 1986. All animals were males aged 8–10 weeks.
Treatments and Tissue Processing
Mice received an intraperitoneal injection of rat recombinant
CNTF (R&D Systems, Minneapolis, MN, USA; 0.3mg/kg
of body weight) and/or mouse recombinant leptin (Sigma-
Aldrich, Saint Louis, MO, USA; 3mg/kg of body weight) for
different periods of time (see Results). Control mice were
injected with pyrogen-free saline. The volumes of CNTF,
leptin, and vehicle ranged from 180 to 220µl according
to body weight; injections were performed with Hamilton
syringes. For morphological analyses, mice were anesthetized
with 100mg/kg ketamine (Ketavet, Farmaceutici Gellini, Aprilia,
Italy) in combination with 10mg/kg xylazine (Rompum, Bayer
AG, Leverkusen, Germany) and perfused transcardially with
4% paraformaldehyde in 0.1M phosphate buffer (PB), pH 7.4.
Brains were carefully removed from the skull, postfixed in the
same fixative solution for 24 h at 4◦C, and washed in PB.
Free-floating 40-µm-thick coronal brainstem sections were cut
with a Leica VT1200S vibratome (Leica Microsystems, Vienna,
Austria) and kept in phosphate buffered saline (PBS), pH
7.4, at 4◦C until use in immunohistochemical experiments.
Adjacent sections were used to identify the exact location
of individual brainstem nuclei and areas by Nissl staining
(Paxinos and Franklin, 2001). For RT-qPCR assays, animals were
anesthetized and decapitated, the brain was rapidly removed
from the skull and placed ventral side up on a pre-cooled
adult mouse sagittal brain matrix (ASI Instruments, Warren,
MI, USA). A 2mm-thick midsagittal slice was cut from each
brain; the area postrema and the bottom portion of the tuberal
hypothalamus, containing the ME and arcuate nucleus, were
micropunched with a size 1.0mm Harris Uni-Core device
(Electron Microscopy Sciences, Hatfield, PA, USA). Samples
were snap-frozen in liquid nitrogen and stored at –80◦C. The
remaining part of the slice was fixed, cut, and stained according
to standard procedures to assess whether micropunching was
successful. Samples from sections where the area postrema or the
mediobasal hypothalamus were not precisely dissected out were
discarded.
Peroxidase Immunohistochemistry
Immunohistochemical detection of P-STAT3, P-STAT1, and P-
STAT5 was performed using unmasking procedures (Frontini
et al., 2008). Free-floating sections were reacted with 1% NaOH
and 1% H2O2 (20min), 0.3% glycine (10min), and 0.03%
sodium dodecyl sulfate (10min). After rinsing in PBS, they
were blocked with 3% normal goat serum (in 0.2% Triton
X-100; 60min) and incubated with the primary antibodies at
appropriate dilutions (Table 1) in PBS, overnight at 4◦C. The
next day, after a thorough rinse in PBS, sections were incubated
in 1:200 v/v biotinylated secondary antibody solution (in PBS;
30min), rinsed in PBS, and incubated in avidin-biotin peroxidase
complex (ABC Elite PK6100, Vector Laboratories, Burlingame,
CA, USA), washed several times in PBS, and finally incubated
in 3,3′ diaminobenzidine tetrahydrochloride (0.05% in 0.05M
Tris with 0.03% H2O2; 5min). After immunohistochemical
staining, sections were mounted on slides, air-dried, dehydrated
in ethanol, cleared with xylene, and covered with Entellan.
Staining was not detected when the primary antibody was
omitted.
TABLE 1 | Primary antibodies used in this study.
Description Marker Host/isotype IHC IF Manufacturer
Signaling Anti-phospho-specific-(Tyr705)-STAT3 Rabbit/IgG 1:1000 1:700 9131, Cell Signaling Technology Inc. (Beverly,
MA, USA)
Goat/IgG 1:1000 1:700 Sc-7993, Santa Cruz Biotech. (Santa Cruz, CA,
USA)
Anti-phospho-specific-(Tyr701)-STAT1 Rabbit/IgG 1:1000 1:700 9167, Cell Signaling Technology Inc.
Anti-phospho-specific-(Tyr694)-STAT5 Rabbit/IgG 1:1000 1:700 9314, Cell Signaling Technology Inc
Cell Marker Choline Acetyltransferase (ChAT) Rabbit/IgG 1:1000 AB143, Merk Millipore (Darmstadt, Germania)
Dopamine β Hydroxylase (DBH) Rabbit/IgG 1:500 PA5-34664, Thermo Fisher Scientific (Waltham,
Massachusetts, USA)
Glial Fibrillary Acidic Protein (GFAP) Mouse/IgG 1:1000 G3893, Sigma-Aldrich (St Louis, MO, USA)
Glutamic acid decarboxylase 67 (GAD67) Mouse/IgG 1:800 MAB 5406, Merk Millipore
Human Neuronal Protein (HuC/D) Mouse/IgG 1:50 A21271, Life technologies (Carlsbad, CA, USA)
Nestin Mouse/IgG 1:300 MAB353, Merk Millipore
Tryptophan hydroxylase 2 (TPH2) Rabbit/IgG 1:700 51124, Cell Signaling Technology Inc.
Vimentin Goat/IgG 1:300 sc-7557, Santa Cruz Biotech.
Activity marker c-Fos Goat/IgG 1:5000 1:4000 sc-52-G, Santa Cruz Biotech.
Anti-CNTF CNTF Goat/IgG 1:100 1:50 AF-557-NA, R&D Systems (Minneapolis, MN,
USA)
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Immunohistochemical detection of CNTF was performed
according to standard procedures. In brief, free-floating sections
were reacted with 0.3% H2O2 (in PBS; 30min) to block
endogenous peroxidase, rinsed with PBS, and incubated in a
3% normal serum blocking solution (in PBS; 60min). Then
they were incubated with the specific polyclonal goat serum
(Table 1) in PBS, overnight at 4◦C. After incubation with the
primary antibody, the procedure was identical to the above
described procedure for immunohistochemical detection of P-
STAT proteins. Staining was not observed when the primary
antibody was omitted.
Double-Labeling and Confocal Microscopy
For double-labeling experiments, free-floating sections were
processed according to the P-STAT protocol up to incubation
with the primary antibody. They were then incubated overnight
in a mixture of two appropriately diluted primary antibodies
raised in different species (Table 1). The next day, sections
were washed twice with PBS and incubated in a cocktail
of fluorophore-linked secondary antibodies at a dilution of
1:100 in PBS for 1 h at room temperature. The secondary
antibodies were Alexa Fluor R©488 donkey anti-goat IgG,
Alexa Fluor R©488 donkey anti-mouse IgG, Alexa Fluor R©555
donkey anti-mouse IgG, Alexa Fluor R©647 donkey anti-mouse
IgG, and Alexa Fluor R©555 donkey anti-rabbit IgG (all from
Invitrogen, Carlsbad, CA, USA). Sections were subsequently
washed twice with PBS, mounted on standard glass slides,
air-dried, and coverslipped using Vectashield mounting
medium (Vector). Sections were viewed under a motorized
Leica DM6000 microscope at different magnifications.
Fluorescence was detected with a Leica TCS-SL spectral
confocal microscope equipped with an Argon and He/Ne mixed
gas laser. Fluorophores were excited with the 488, 543, and
649 nm lines and imaged separately. Images (1024 × 1024
pixels) were obtained sequentially from two channels using
a confocal pinhole of 1.1200 and stored as TIFF files. The
brightness and contrast of the final images were adjusted
using Photoshop 6 (Adobe Systems, Mountain View, CA,
USA).
Morphometric Analysis
The percentage of P-STAT3-positive cells also expressing P-
STAT1 or P-STAT5 and the percentage of P-STAT3-positive cells
also expressing one of the cell markers listed in Table 1 (see the
Results) were calculated in 5 alternate, double-stained, coronal
brainstem sections from 3 mice/experimental group. In each
section, 12 non-overlapping fields of the area postrema were
randomly selected at 60x magnification, and the number of
labeled nuclei, or cells, was counted on a fixed confocal plane.
A total number of 1343 and 1306 nuclei were examined to
evaluate P-STAT3/1 and P-STAT3/5 co-localization, respectively.
For P-STAT3 and HuC/D, nestin, vimentin, or glial fibrillary
acidic protein (GFAP) co-localization, a total number of 907,
926, 754, and 1028 cells, respectively, were evaluated. The
percentage of c-Fos-positive nuclei also expressing P-STAT3 in
mice treated with both CNTF and leptin was calculated in 3
alternate, double-stained, coronal sections of the caudal NTS
from 3 mice. In each section, 10 non-overlapping fields of the
caudal NTS were randomly selected at 60x magnification and
examined on a fixed confocal plane. A total of 1258 nuclei were
examined. Results are given as mean ± standard error of the
mean (SEM).
RNA Isolation, cDNA Synthesis, and
RT-qPCR
Total RNA was extracted from micropunched tissue after
homogenization using RNeasy Micro kit (Qiagen, Milano,
Italy) according to the manufacturer’s instructions. Three
separate micropunches of the area postrema and mediobasal
hypothalamus were pooled by pipetting samples onto the
same purification column to increase RNA yield. The quality
and quantity of isolated total RNA was evaluated using the
2100 BioAnalyzer (Agilent Technologies, Milano, Italy). One
microliter from each isolated RNA sample was analyzed with
RNA 6000 Pico LabChips (Agilent Technologies). To determine
mRNA levels, 500 ng of RNA was reverse-transcribed with a
High-Capacity cDNA RT Kit with RNase Inhibitor (Thermo
Fisher Scientific, Monza, Italy) in a total volume of 20µl.
Real time gene expression was analyzed in triplicate by using
TaqMan Gene Expression Assays (Thermo Fisher Scientific) as
follows: TATA box binding protein (TBP); Mm00446973_m1;
CNTF: Mm00446373_m1; Ciliary Neurotrophic Factor receptor
(CNTFR): Mm00516693_m1; POMC: Mm00435874_m1;
Vimentin: Mm01333430_m1, and Master Mix TaqMan (all
from Thermo Fisher Scientific). The efficiency of each assay was
evaluated using a standard curve with serial dilutions of a known
template, and the equation of the linear regression line, along
with the coefficient of determination (R2), were calculated. The
reaction efficiency was 96.84% for CNTF, 92.56% for CNTFR,
93.71% for POMC, and 95.4% for vimentin. Reactions were
carried out in a Step One Plus instrument (Thermo Fisher
Scientific) using 25 ng of cDNA in a final reaction volume of
20µl and the following thermal cycle protocol: initial incubation
at 95◦C for 10min, followed by 40 cycles of 95◦C for 15 s, and
60◦C for 20 s. A control reaction without reverse transcriptase
in the amplification mixture was included in each sample, to
rule out genomic contamination. Relative mRNA expression
was determined by the 1Ct method (2−1Ct) using TBP levels
as an endogenous control. Differences in starting total RNA and
in cDNA synthesis efficiency among samples were normalized
using TBP expression. Data are presented as histograms
± SEM.
RESULTS
Systemically Administered CNTF Activates
STAT3, STAT1, and STAT5 in Mouse Area
Postrema
To assess whether circulating CNTF exerts a direct, specific effect
on the mouse brainstem, coronal slices from mice treated with
an intraperitoneal injection of vehicle or recombinant CNTF
for 45min were processed for immunohistochemical P-STAT
detection. CNTF dose and treatment duration were in line with
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previous studies (Anderson et al., 2003; Kelly et al., 2004; Severi
et al., 2012, 2013). In the brainstem parenchyma of vehicle-
treated mice, cells exhibiting nuclear P-STAT3, P-STAT1, or P-
STAT5 staining were few, sparse, and weakly labeled, suggesting
that in this, as in other brain areas, Jak-STAT signaling is
highly regulated and its activation level is barely detectable in
normal adult brain (Nicolas et al., 2013). CNTF administration
induced STAT3 (Figure 1A), STAT1 (Figure 1B), and STAT5
(Figure 1C) phosphorylation in the area postrema, where the
nucleus of numerous cells was strongly stained. Double-staining
experiments, performed at different rostrocaudal levels, showed
that P-STAT3 staining was ubiquitous and was also detected in
FIGURE 1 | P-STAT immunohistochemistry in coronal sections of mouse area postrema. After 45min CNTF treatment, P-STAT3 (A), P-STAT1 (B), and
P-STAT5 (C) immunoreactivity was detected in the nucleus of many cells of the area postrema (AP). Insets: the area postrema of control mice processed for
immunohistochemistry against the three P-STAT isoforms. Double-staining and confocal microscopy experiments in a CNTF-treated mouse (D–F): P-STAT3 staining
is ubiquitous and is also found in the funiculus separans (fs), whereas P-STAT1 staining is detected in a smaller number of cells, most of which lie in the central portion
of the area postrema. At higher magnification, the majority of P-STAT3-positive cells also express P-STAT1 (G–I, arrows) or P-STAT5 (J–L), arrows. Panels (G–I) are
enlargements of the areas framed in Panels (D–F), respectively. Bar: (A–F), 120µm; insets of (A–C), 300µm; (G–I), 25µm; (J–L), 18µm.
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the funiculus separans, the glial structure on the ventrolateral
border of the area postrema separating it from the adjacent
nuclei (McKinley et al., 2003), whereas immunoreactivity for
P-STAT1 and, especially, P-STAT5 involved a smaller number
of cells, most of which were located in the central portion of
the area postrema (Figures 1D–F). In addition, the majority
of CNTF-responding cells were positive for at least two STAT
isoform. In particular, 76.91% ± 3.20 (n = 3) of STAT3-
reactive cells were also positive for P-STAT1 (Figures 1G–I),
and 77.86% ± 1.31 (n = 3) of STAT3-positive cells were
also positive for P-STAT5 (Figures 1J–L). Conversely, all P-
STAT1- and P-STAT5-positive cells were also positive for P-
STAT3. We conclude that STAT3 is the main transduction
factor activated by CNTF in the mouse area postrema, and
that several CNTF-responding cells activate STAT3 as well as
STAT1 and/or STAT5. STAT3, STAT1, or STAT5 phosphorylation
was found exclusively in the area postrema. Thus, even though
several cranial nerve sensory and motor nuclei express CNTFRα
(MacLennan et al., 1996; Lee et al., 1997b), the area postrema is
the only brainstem area that is directly responsive to circulating
CNTF.
CNTF-Responsive Cells in the Area
Postrema Include Neurons and Glial Cells
To characterize the phenotype of CNTF-responsive cells
in the area postrema, double-immunostaining and confocal
microscopy experiments were performed using mature and
immature neuronal and glial markers (Table 1). Results showed
that 14.27% ± 0.25 (n = 3) of P-STAT3-positive cells
were HuC/D-positive neurons (Figures 2A–C), whereas 11.97%
± 0.11 (n = 3) co-localized with nestin (Figures 2D–F),
11.51% ± 1.42 (n = 3) with vimentin (Figures 2G–I),
and 6.57% + 0.81 (n = 3) with the GFAP (Figures 2J–L).
Notably, since nestin, vimentin, and GFAP immunoreactivity
was seen in cell processes rather than cell bodies, the extent
of co-localization was probably underestimated. However,
even neglecting possible marker co-expression in the same
cell (Furube et al., 2015), the approach achieved phenotypic
characterization of only about half of CNTF-responsive cells,
leaving out a large proportion of CNTF-responsive cells that were
perhaps oligodendrocytes, microglia, endothelial cells, and/or
pericytes. Altogether, these data document that circulating CNTF
acts on both neurons and glial cells of the area postrema,
where a considerable proportion of CNTF-responsive cells
exhibit immaturity markers such as nestin and vimentin. The
situation is highly reminiscent of the action of CNTF on
the hypothalamic ME, where CNTF treatment activates P-
STATs in neurons, ependymal cells, and underlying radial-
like glial cells showing markers of immaturity (Severi et al.,
2015).
The Neurochemical Nature of
CNTF-Responsive Area Postrema Neurons
The area postrema is a “sensory” circumventricular organ,
because it contains a large number of neuronal perikarya
with their dendritic trees, which receive chemical inputs from
the bloodstream (Johnson and Gross, 1993). As previously
described in rats (Armstrong et al., 1981; Miceli et al., 1987;
Tago et al., 1989; Fong et al., 2005), we detected small and
medium-sized catecholaminergic, serotoninergic, GABAergic
and cholinergic neurons in the mouse area postrema. To
establish whether circulating CNTF distinctively engages one of
these neuronal populations, brain sections from CNTF-treated
mice were double-stained with P-STAT3 and dopamine-beta-
hydroxylase (DBH), tryptophan hydroxylase (TPH), glutamic
acid decarboxylase 67 (GAD67) and choline acetyltransferase
(ChAT), which are widely used markers of noradrenergic,
serotoninergic, GABAergic and cholinergic neurons, respectively
(Table 1). CNTF-responsive P-STAT3-positive neurons only very
rarely did express DBH (Figures 3A–C) or TPH (Figures 3D–F),
whereas evidence of co-localization was never found for
the GABAergic (Figures 3G–I) and cholinergic (Figures 3J–L)
neurons. Jak-STAT pathway activation by cytokines or growth
factors, including CNTF, is usually followed by expression of
the immediate early gene c-Fos, a marker of neuronal activation
(Sheng and Greenberg, 1990). To gain insights into the effect(s)
of CNTF on area postrema neurons, we looked for co-localization
of P-STAT3-HuC/D and c-Fos in sections from mice treated
with CNTF for 80min, a treatment duration that induces c-
Fos transcription while maintaining the Jak-STAT pathway active
(Hubschle et al., 2001; Severi et al., 2015). Interestingly, c-Fos
positivity was found in nearly all non-neuronal CNTF-responsive
cells, but not in CNTF-responsive HuC/D-positive neurons
(Figures 3M–P).
Systemically Administered CNTF Induces
Widespread c-Fos Expression in the
Mouse NTS
Further insights into the action of circulating CNTF on brainstem
feeding centers were obtained by examining P-STATs and nuclear
c-Fos expression and tissue distribution in mice treated with
an intraperitoneal injection of vehicle or CNTF for 120min, a
time interval that is known to induce full protein expression
of the gene (Sheng and Greenberg, 1990; Hubschle et al.,
2001; Severi et al., 2015). P-STAT3 (Figures 4A–C), P-STAT1,
and P-STAT5 were again detected only in the area postrema
of CNTF-treated mice where, however, staining was reduced
compared with mice treated for 45min, suggesting that after
120min Jak-STAT signaling had begun to abate. In these
mice, STAT-positive nuclei were mainly detected in the GFAP-
positive tanycyte-like cells forming the funiculus separans (insets
of Figures 4A–C). As expected, c-Fos was barely detectable
in vehicle-injected mice. In CNTF-treated mice, numerous
intensely positive cells were detected not only in the area
postrema, but also in the rostral (Figure 4D) and caudal NTS
(Figure 4E; Watson et al., 2012). In the former area very
few neurons exhibited weak c-Fos expression (Figures 4F–H),
whereas in the NTS all the c-Fos-immunoreactive cells were
neurons, as demonstrated by their immunoreactivity for the
neuronal marker HuC/D (Figures 4I–K). In some sections, c-
Fos immunoreactivity was also detected in the DMX. Thus,
use of the cholinergic marker ChAT to achieve accurate DMX
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FIGURE 2 | Phenotypic characterization of CNTF-responsive cells in the mouse area postrema. Double-staining and confocal microscopy experiments
showed that in mice treated with CNTF for 45min some P-STAT3-positive cells co-localized with the neuronal marker HuC/D (A–C, arrows), the intermediate filament
proteins nestin (D–F, arrows) or vimentin (G–I, arrows), or the glial marker GFAP (J–L, arrows). Bar:(A–C), 12µm; (D–L), 8µm.
identification (Figures 5A–C) allowed demonstrating that CNTF
also activated a few, large parasympathetic DMX neurons
(Figures 5D–F) and some small and medium-sized cholinergic
neurons found in the NTS, the DMX and the intervening area
(Figures 5G–I). Collectively, these data suggest that circulating
CNTF acts directly on area postrema cells and indirectly on
NTS neurons and, to a lesser extent, on cholinergic DMX
neurons.
The Action of CNTF on the Mouse
Brainstem does not Depend on Leptin but
Engages a Population of
Leptin-Responsive NTS Neurons
The potential clinical value of CNTF and CNTF agonists as
weight-reducing agents is mostly related to their ability to
bypass leptin resistance in animal models (Gloaguen et al., 1997;
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FIGURE 3 | Phenotypic characterization of CNTF-responsive neurons in the mouse area postrema. Double-staining and confocal microscopy experiments
showed that in mice treated with CNTF for 45min a few P-STAT3-positive cells were positive for dopamine-beta-hydroxylase (DBH; A–C, arrows) or tryptophan
hydroxylase (TPH; D–F, arrows). In contrast, glutamic acid decarboxylase 67 (GAD67; G–I, arrowheads) and choline acetyltransferase (ChAT; J–L, arrowheads)
expressing neurons never co-localized with P-STAT3. In a mouse treated with CNTF for 80min (M–P), some P-STAT3-positive cells also expressed c-Fos (arrows),
whereas the P-STAT3 HuC/D-positive neurons did not (arrowheads). Bar: (A–C), 10µm; (D–L), 12µm; (M–P), 18µm.
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FIGURE 4 | P-STAT3 and c-Fos immunohistochemistry in coronal brainstem sections from mice treated with CNTF for 120min. Double-staining and
confocal microscopy experiments (A–C) still showed some P-STAT3-positive cells in the area postrema, including the funiculus separans (fs), where CNTF-responsive
cells are positive for GFAP (insets, arrows). Immunoperoxidase histochemistry showed nuclear c-Fos expression in numerous cells of the rostral (D) and caudal (E)
portions of the solitary tract nucleus (NTS) and in the area postrema (E, AP). 4V, fourth ventricle. Double-staining experiments demonstrated that in the area postrema
(F–H) only few HuC/D-positive neurons expressed weak c-Fos staining (arrows), whereas in the NTS (I–K) all c-Fos-positive cells were HuC/D-positive neurons
(arrows). Insets of (A–C) are enlargements of the corresponding framed areas. In (D) and (E), insets on the left show the corresponding structures from a control
mouse processed for c-Fos immunohistochemistry; those on the right show the adjacent Nissl-stained section. Bar: (A–C), 150µm; insets of (A–C), 20µm; (D) and
(E), 150µm; insets of (D) and (E), 400µm; (F–K), 10µm.
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FIGURE 5 | c-Fos activation in brainstem cholinergic neurons by CNTF. Double-staining and confocal microscopy experiments after 120min CNTF treatment
showed c-Fos expression (B) in cells of the area postrema (AP), solitary tract nucleus (NTS) and dorsal motor nucleus of the vagus (DMX), depicted by
immunofluorescent detection of choline acetyltransferase (ChAT,A), the marker of cholinergic pre-ganglionic vagal neurons. Panels (D–F) are the enlargements of the
corresponding areas framed in (A–C), showing two large DMX cholinergic neurons expressing c-Fos (arrows). Some small cholinergic neurons of the NTS were also
c-Fos-positive (G–I, arrows). Sol, solitary tract. Bar: (A–C), 50µm; (D–F), 10µm; (G–I), 25µm.
Lambert et al., 2001) as well as humans (Ettinger et al., 2003). To
assess whether the effects of CNTF on brainstem centers depend
on leptin or leptin signaling, the expression and distribution of P-
STATs and c-Fos were examined in the brainstem of genetically
obese ob/ob and db/db mice, which lack leptin and the long
form of the leptin receptor, respectively. Results showed STAT3,
STAT1, and STAT5 activation in the area postrema of ob/ob
(Figures 6A–C) and db/db (Figures 6E–G) mice after 45min
CNTF treatment, and c-Fos expression in the NTS after 120min
CNTF treatment (Figures 6D,H). P-STATs and c-Fos expression
and distribution did not display obvious differences in wild-
type and genetically obese models, suggesting that the action of
CNTF on the brainstem is not dependent on leptin or leptin
signaling. To promote satiation, circulating leptin acts not only
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FIGURE 6 | Relationship between CNTF and leptin signaling in the mouse brainstem. CNTF treatment for 45min induced STAT3 (A,E), STAT1 (B,F), and
STAT5 (C,G) phosphorylation in the area postrema of ob/ob (A–D) and db/db (E–H) obese mice and c-Fos expression (D,H) in the area postrema (AP) and solitary
tract nucleus (NTS). Treatment with leptin for 25min (J) activated STAT3 signaling in neurons and fibers in the caudal portion of the NTS, enlarged in the inset. (I)
corresponding structures from a control mouse processed for P-STAT3 immunohistochemistry. Inset of I shows the adjacent Nissl-stained section. Double-staining
and confocal microscopy experiments in a coronal brainstem section from a mouse treated for 120min with CNTF to induce c-Fos expression and with leptin for
25min to induce STAT3 activation (K–M) show some NTS neurons (enlarged in the insets, arrows) expressing both c-Fos and P-STAT3. Insets of (J) and (K–M) are
enlargements of the corresponding framed areas. Bar:(A–C) and (E–G), 150µm; (D, H–J,) and (K–M), 120µm; insets of (J) and (K–M), 30µm; inset of (I), 300µm.
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on hypothalamic neuronal networks but also on theDVC, namely
the NTS, where it gains direct access to first-order neurons and
activates the Jak-STAT3 pathway (Hosoi et al., 2002; Hayes et al.,
2010). Indeed, treating mice with leptin for as little as 25min
induced STAT3 phosphorylation in a discrete subset of neurons
and projections in the caudal NTS (Figures 6I,J). Importantly,
25min treatment was insufficient to induce c-Fos expression in
leptin-responsive neurons (Hubschle et al., 2001; Frontini et al.,
2008; not shown). Based on the above findings, P-STAT3 and
c-Fos co-localization was assessed in caudal NTS neurons from
mice treated with CNTF for 120min, to induce c-Fos expression,
and with leptin for 25min, to induce STAT3 phosphorylation.
Results showed that 14.11% ± 2.85 (n = 3) of c-Fos-positive
and CNTF-responsive neurons in the caudal NTS were also
positive for P-STAT3 (Figures 6K–M). This small NTS neuronal
population is thus responsive to both CNTF and leptin, possibly
representing an extrahypothalamic site where CNTF bypasses
leptin resistance.
Discrepancy between CNTF and CNTFR
Expression in the Mouse Area Postrema
To identify possible endogenous CNTF source(s) capable
of stimulating area postrema cells, we performed CNTF
immunohistochemistry. Specific CNTF staining was detected
throughout the rostrocaudal extent of the area postrema, where it
was confined to thick projections and few, small cellular profiles
that were mainly located in, or close to the funiculus separans
(Figure 7A) and the meningeal sheet on the dorsolateral border
of the area postrema, separating it from the subarachnoid space
(Figure 7B). Sometimes, long and strongly stained tanycyte-
like projections branched from the funiculus separans or the
meningeal sheet and penetrated into the brain parenchyma
(left inset of Figure 7B). Notably, CNTF-knockout mice showed
no specific staining at any of these sites (right insets of
Figures 7A,B). Double-labeling experiments demonstrated that
the CNTF-positive elements were often positive for GFAP
(Figures 7C–E). This suggests that in the mouse area postrema
as in other brain areas CNTF is produced by glial cells,
even though CNTF staining in these cells may conceivably
be due also to CNTF uptake from other sources. Overall,
CNTF immunoreactivity was weak and sparse, and inconsistent
with the high responsiveness to exogenous CNTF seen in
area postrema cells. This prompted RT-qPCR quantification
of CNTF and CNTFRα in micropunched brainstem tissue
containing the area postrema and comparison with the amount
found in micropunched hypothalamus tissue containing the
ME, where our group has documented a distinctive spatial
mismatch between the CNTF-producing and CNTF-responding
cells (Severi et al., 2012, 2015). Histological analysis confirmed
that themicropunched slices contained neither the area postrema
nor the mediobasal hypothalamus (Supplementary Figure 1)
and RT-qPCR showed that the hypothalamus tissue was enriched
with POMC (Figure 7F), whereas the brainstem samples were
enriched with vimentin (Figure 7G). CNTFRα expression was
264.94 times higher than CNTF expression in the hypothalamus
samples (Figure 7F) and 424.89 times higher in brainstem tissue
(Figure 7G). These findings lend support to the hypothesis that
most CNTFRα-bearing cells of the mouse ME and area postrema
are more likely to be exposed to blood- or cerebrospinal fluid-
derived CNTF than to locally produced CNTF.
DISCUSSION
In humans, morbid obesity is thought to occur when the brain
underestimates the body energy reserves, misinterpreting the
nutritional and metabolic signals conveyed to hypothalamic
and brainstem centers by peripheral peptides and metabolites
through specific transporters in the blood brain barrier
(BBB) and/or through sensory circumventricular organs. This
mechanism is exemplified by leptin, the chief satiety hormone,
which crosses the BBB and provides to the brain information
about body lipid stores in white fat (Friedman, 2014). Indeed,
leptin resistance, i.e., the inability of high circulating leptin levels
to reduce food intake by a commensurate amount and increase
energy expenditure is a near-universal feature of human obesity
(Friedman, 2014; Balland andCowley, 2015). The ability of CNTF
and its analogs to overcome leptin resistance in mouse models of
obesity (Gloaguen et al., 1997; Lambert et al., 2001) and in obese
patients (Ettinger et al., 2003) underscores its potential as an anti-
obesity drug. Moreover, insights into its anti-obesity action(s)
may disclose novel cellular mechanisms and brain pathways and
centers involved in energy balance regulation, offering novel
targets for anti-obesity drugs.
The anorectic role of CNTF was first ascribed to its ability
to activate Jak-STAT3 signaling in NPY- and POMC-containing
neurons of the hypothalamic arcuate nucleus (Lambert et al.,
2001; Anderson et al., 2003; Janoschek et al., 2006). Subsequently,
it was shown that in adult mice it induces generation of
new neurons, whose integration into the hypothalamic circuits
involved in energy balance regulation, may render the animals
more leptin-sensitive (Kokoeva et al., 2005). Notably, transgenic
mice with a conditional CNTFRα deletion in leptin receptor-
containing neurons display no change in the anorectic response
to CNTF (Stefater et al., 2012), suggesting that leptin-responsive
hypothalamic neurons are not required for the satiety effect
induced by CNTF, and that CNTF likely exerts a central
control on food intake and energy expenditure through multiple,
redundant mechanisms. In a recent mouse study, we advanced
the hypothesis that the glial cells of the ME, the secretory
circumventricular organ of the tuberal hypothalamus, could
be a further CNTF target. Indeed, CNTF treatment activated
STAT3 in ME and arcuate nucleus neurons, and STAT3, STAT1,
and STAT5 in ependymal and radial-like glial cells of the ME,
many of which were positive for immaturity markers such as
nestin and vimentin (Severi et al., 2015). The effects of CNTF
on cells expressing markers of immaturity and plasticity may
relate to possible, long-lasting, structural neuronal and/or glial
modifications that may underpin the prolonged and sustained
satiety effect that follows CNTF administration (Gloaguen et al.,
1997; Lambert et al., 2001; Ettinger et al., 2003).
In the present study, we report strong Jak-STAT signaling
activation in the area postrema and induction of strong c-Fos
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FIGURE 7 | CNTF and CNTFRα expression in the mouse area postrema. Peroxidase immunohistochemistry demonstrated CNTF immunoreactivity in small
portions of the funiculus separans (A, fs) and of the meninges (A,B, arrowheads). The antibody mainly stained cellular projections (left-side insets, arrowheads) and
rarely cell somata (left-side inset in B, arrow). In A and B, insets on the left show the enlargements of the corresponding framed areas, whereas those on the right
show the corresponding structures processed for CNTF immunohistochemistry from a CNTF-knockout mouse. Double-labeling experiments (C–E) showed that
CNTF-immunoreactive structures were positive for the GFAP (arrows). RT-PCR demonstrated that in hypothalamic specimens CNTFRα mRNA was 264.94 times
higher than that of the CNTF (F), whereas in the brainstem samples it was 424.89 times higher than that of its ligand (G). Bar: (A,B), 100µm; left insets of (A,B),
60µm; right insets of (A,B), 300µm; (C–E), 50µm.
expression in the NTS following intraperitoneal CNTF injection,
showing that CNTF also affects the brainstem centers involved
in feeding and energy balance regulation. Its action in obese
ob/ob and db/db mice, which lack leptin or the functional leptin
receptor, respectively, was similar to that found in wild-typemice,
suggesting that neither leptin nor leptin signaling is required for
the action of CNTF on brainstem centers. This indicates that
such centers are further sites where CNTF may exert leptin-
independent effects on food intake and the energy balance.
CNTF activated Jak-STAT signaling in glial and, to a
lesser extent, neuronal cells of the area postrema. This
circumventricular organ is crucially involved in brainstem energy
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balance control, because it contains neurons that detect several
circulating energy homeostasis-related signals, including amylin,
cholecystokinin, glucagon-like peptide-1 (GLP-1), peptide YY,
and ghrelin (Price et al., 2008; Young, 2012). CNTF activates
STAT3, STAT1, and STAT5 in nestin- and vimentin-positive
glial cells. The expression profile of the marker proteins of area
postrema CNTF-responsive cells is thus closely reminiscent of
the profile described by our group in the ME (Severi et al.,
2015). At present, the action of CNTF on area postrema
glial cells can only be surmised. Sensory circumventricular
organs in adult rodents (Bennet et al., 2009; Hourai and
Miyata, 2013; Lin et al., 2015) and humans (Sanin et al.,
2013) have recently been shown to be a rich source of stem
cells that can give rise to oligodendrocytes, astrocytes, and
neurons, thus potentially providing novel cells to adjacent
brain regions. Two types of neural stem cells have been
identified in these niches: nestin-positive tanycyte-like cells and
nestin-positive astrocyte-like cells (Furube et al., 2015). Our
data showing that CNTF activates multiple STAT isoforms in
vimentin- and/or nestin-positive glial cells suggest that CNTF
may promote neurogenesis and/or gliogenesis also in the mouse
brainstem, as previously documented in the hypothalamus
(Kokoeva et al., 2005). Vascular endothelial growth factor-
dependent angiogenesis induces continuous vascular remodeling
in circumventricular organs, including the area postrema (Morita
et al., 2015) and the ME (Langlet et al., 2013a). The action
of CNTF on the area postrema could thus also be related
to glio-vascular rearrangements resulting in greater vascular
permeability and contact between circulating metabolites and
adjacent brain areas, namely the NTS. Notably, CNTF could also
target vimentin-positive ependymal tanycyte-like cells, which
have recently been shown to act as a barrier against the diffusion
of blood-borne molecules to cerebrospinal fluid (Langlet et al.,
2013b). Interestingly, increased neurogenesis and gliogenesis
is seen in sensory circumventricular organs after injury both
in mice (Lin et al., 2015) and humans (Sanin et al., 2013).
Prompt CNTF upregulation is found in the brain after injury
or deafferentation (Guthrie et al., 1997; Lee et al., 1997a;
Watt et al., 2006), and CNTF is regarded as a protective
factor functioning through activated release after nerve tissue
stress or injury. In pathological conditions, endogenous CNTF
delivered to the area postrema from the ependyma through
the cerebrospinal fluid (Severi et al., 2012), from the periphery
through the bloodstream (Guillet et al., 1995; Laaksovirta
et al., 2008) or else produced locally by funiculus separans
glial and tanycyte-like cells (present study) has the potential
to induce reactive neurogenesis and gliogenesis. This action
could be restricted to the area postrema or else involve other
circumventricular organs, such as the subfornical organ, the
vascular organ of the lamina terminalis, and the ME, since
in all of them CNTF activates multiple STAT isoforms (Severi
et al., 2012, 2013, 2015). Interestingly, Jak-STAT signaling in
glial cells of the sensory circumventricular organs, including
the area postrema, has been related to neuroendocrine and
behavioral host responses to peripheral inflammation (Roth et al.,
2004), raising the possibility that CNTF is also involved in
the brain inflammatory response at these sites. Whether this
finding is connected with the physiopathology of obesity, which
is characterized by a chronic and systemic inflammatory state
(Gregor and Hotamisligil, 2011; Giordano et al., 2016), remains
to be established.
CNTF activated the Jak-STAT3 pathway in a small percentage
of area postrema neurons, which were not a homogeneous and
distinctive population of cholinergic, GABAergic, dopaminergic,
or serotoninergic neurons, i.e., the most common neurochemical
phenotypes found in the rodent area postrema (Armstrong et al.,
1981; Miceli et al., 1987; Tago et al., 1989; Fong et al., 2005). This
raises the interesting possibility that CNTF acts on peptidergic
neurons. Remarkably, these CNTF-responsive neurons did not
activate c-Fos, or did so late and weakly. This may suggest
that CNTF induces the transcription of immediate early genes
other than c-Fos (Kelly et al., 2004), or perhaps that it exerts
an inhibitory effect on area postrema neurons. Indeed, c-Fos
is a widely used marker of functionally activated neurons, and
absence of c-Fos expression may indicate that it exerts an
inhibitory action on CNTF-responsive neurons. However, a well-
recognized problem with the use of this immediate early gene
is that it only labels neurons undergoing a significant increase
in action potential frequency, whereas inhibition as well as
small firing pattern alterations are likely to be missed (Hoffman
et al., 1993; Kovács, 2008). To complicate the picture further, c-
Fos induction in area postrema neurons is seen not only after
treatment with satiety factors, such as cholecystokinin (Covasa
and Ritter, 2005) and amylin (Potes and Lutz, 2010), but also
after treatment with circulating molecules that exert opposite
effects, such as ghrelin (Li et al., 2006). Thus, electrophysiological
studies are needed to clarify the action of CNTF on area
postrema neurons. Anyway, the present findings suggest that
the effect exerted by CNTF on area postrema neurons is very
different from the one exerted by amylin and GLP-1, i.e.,
circulating satiety factors that typically act on the area postrema
by inducing c-Fos in the noradrenergic neurons projecting to
the NTS (Yamamoto et al., 2003; Price et al., 2008; Potes et al.,
2010).
In CNTF-treated mice, c-Fos activation was widespread
throughout the rostrocaudal extent of the NTS and, to a
lesser extent, in the DMX. The NTS receives afferent fibers
from the facial, glossopharyngeal and vagus nerves, which
convey gustatory, mechanical, hormonal, and metabolic visceral
information. It is reciprocally connected with other brainstem
centers, including the area postrema, the DMX, the lateral
parabrachial nuclei, and the hypothalamus, including the arcuate
nucleus and the paraventricular nucleus (Van der Kooy and
Koda, 1983; Shapiro and Miselis, 1985; Watson et al., 2012).
The NTS contains a number of neurochemically different
neuronal populations and constitutes a crucial integrative node
for several cardiovascular, respiratory, and metabolic responses.
Non-activation of the Jak-STAT pathway in NTS and DMX
neurons after CNTF treatment suggests that circulating CNTF
lacks direct access to them, and that their activation is secondary
to the action of CNTF on other centers that are primarily
targeted by it. The finding that CNTF acts on area postrema
neurons suggests that these neurons are primarily engaged
by circulating CNTF, and that they secondarily can stimulate
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NTS and DMX neurons. However, the widespread activation
of NTS neurons seen in CNTF-treated mice may also depend
on descending projections of CNTF-activated hypothalamic
neurons (Kelly et al., 2004; Janoschek et al., 2006; Purser et al.,
2013; Severi et al., 2015) or on a still unappreciated action
of CNTF on peripheral sensory nerve endings. Evaluation of
c-Fos activation in the NTS of CNTF-treated animals after
surgical ablation of the area postrema or after deafferentation
by systemic capsaicin treatment or subdiaphragmatic vagotomy
may provide insights on the route by which CNTF activates NTS
neurons. Both the rostral and the caudal portion of the NTS
are engaged following CNTF administration. This activation is
distinctively different from that induced by circulating leptin,
which activates Jak-STAT3 signaling in neurons found in the
caudal half of the NTS (Hosoi et al., 2002; Hayes et al., 2010).
This raises the possibility that, in addition to food-related
signals, CNTF could be involved in detection and/or analysis of
gustatory and other sensory visceral modalities. However, our
data show that a small percentage of leptin-responsive neurons
of the caudal NTS also respond to CNTF. Engagement of these
neurons by CNTF may explain the satiety effect exerted by
the peptide at the brainstem level, also in conditions of leptin
resistance.
In conclusion, our findings show that the area postrema
is strongly sensitive to circulating CNTF, which also induces
widespread activation of NTS neurons. Interestingly, nausea,
vomiting and cough are among the most frequent adverse events
reported by patients treated with Axokine (Ettinger et al., 2003).
The area postrema is the best known chemoreceptor trigger zone
involved in the emetic reflex (Hornby, 2001), and the medullary
portion of the brainstem contains the distributed central pattern
generators of vomiting and cough. By showing a strong effect of
CNTF at these sites, our data suggest that these adverse events
related to CNTF administration are consistent with an effect of
the peptide on human brainstem centers.
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Supplementary Figure 1 | Representative Nissl-stained sections from
control (A,C) and micropunched (B,D) slices at diencephalic (C,D) and
brainstem (A,B) levels. The dotted area depicts the micropunched tissues
containing the area postrema (B, AP) and the mediobasal hypothalamus (D, Hy).
NTS, nucleus of the solitary tract. DMX, dorsal motor nucleus of the vagus. XII,
hypoglossal nerve. T, thalamus. M, mesencephalon. Bar: A and B = 600µm; C
and D = 1.2mm.
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